Regent Medical Merges With Molnlycke


NORCROSS, Ga. -- Regent Medical Americas, the North American arm of Regent Medical Ltd., announces completion of Regent Medical Ltds merger with Mölnlycke Health Care and Medlock Medical, creating a leading medical products group, Mölnlycke Health Care Group, with a strong brand focus. 

According to Lundy Fields, formerly Regent Medical Americas president and now Mölnlycke Health Care U.S. president, the merger of Gothenburg, Sweden-based Mölnlycke Health Care with two Manchester, United Kingdom-based companies (Regent Medical and Medlock Medical), results in a new force in global healthcare. The compelling strategic fit between Mölnlycke and Regent, a leading surgical supplier known for its two brands Biogel® powder-free surgical gloves and HIBICLENS® antiseptic/antimicrobial skin cleanser, and Medlock, a niche wound care company, creates a company with a significantly enhanced product range and opportunity in the market, Fields said.

The companys two strategic divisions will be Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division will encompass a leading manufacturer and supplier of powder-free surgical gloves (Biogel® surgical gloves) and a leading supplier of skin cleanser (Hibiclens® and Hibistat® antiseptics). A leader in trauma and pain management, the Wound Care Divisions market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment. 

There are clear synergies between the companies in terms of sales force and distribution as well as in R&D; this, together with a more decentralized approach by management, will see the opportunities for cost savings, increased profitability and an accelerated top line growth.

Commenting on the new strategy, Mölnlycke CEO John Samuel said, The platform for future growth is in place and now it is time for us to focus on improving and expanding our business. Our strategy is two-fold: In Surgical, we plan to take advantage of the growing market need for single use products and further expand geographically; and in Wound Care, we plan to grow the advanced wound care business from the strong base of the market leading Safetac® technology both with innovative new products and further geographical spread.

Related Videos
Antimicrobial Resistance (Adobe Stock unknown)
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Lucy S. Witt, MD, investigates hospital bed's role in C difficile transmission, emphasizing room interactions and infection prevention
Chikungunya virus, 3D illustration. Emerging mosquito-borne RNA virus from Togaviridae family that can cause outbreaks of a debilitating arthritis-like disease   (Adobe Stock 126688070 by Dr Microbe)
An eye instrument holding an intraocular lens for cataract surgery. How to clean and sterilize it appropriately?   (Adobe Stock 417326809By Mohammed)
Association for the Health Care Environment (Logo used with permission)
Related Content